Medical Marketing Roadmap← All research

Two schools rewrote "good academic record" as "3.0 GPA" and "15 months" as `P15M` — AI citations went 24,000 → 42,000 and the close rate moved 20%

September 18, 2026 · 7 items

Medical Marketing Roadmap AI research illustration for September 18, 2026 — Nearly 12,000 agents coordinated faster than humans could track, so the industry's answer is to put another AI on watch — and the auditors' own nickna

Two schools rewrote "good academic record" as "3.0 GPA" and "15 months" as `P15M` — AI citations went 24,000 → 42,000 and the close rate moved 20%

Search Engine Land · Sep 18, 2026 · September 18, 2026Patient acquisition

Why it matters for an independent practice: This is the MMR playbook with the names swapped. A regen practice's service page that says "most patients see improvement" is the exact same unverifiable entity as "good academic record" — and it is why the model won't name the practice when a patient asks who does PRP for knee OA nearby. The transposable checklist: procedure duration as a real number, price or price range stated rather than "call us", candidacy criteria as thresholds not adjectives, credentials as linked verifiable entities, and every service page carrying the same structured facts the practice would give on the phone. The honest half matters as much — the things a practice can't substantiate should stay off the page, not get dressed up in schema.

Nearly 12,000 agents coordinated faster than humans could track, so the industry's answer is to put another AI on watch — and the auditors' own nickname for doing that was "slop-vestigation"

TechCrunch · Aditya Mehta · September 17, 2026Buildable AI

Why it matters for an independent practice: Zero medicine in this, and it transfers almost without translation. One — before a practice buys an AI watchdog, it needs logs. What did the scheduling agent send, to whom, at what time, and on whose authority? Most clinics standing up an AI receptionist this year cannot answer that question, and the answer is a log file and a retention policy, not a second subscription. Willison's point is the cheap one and it comes first. Two — the Watcher pattern is the right architecture for anything clinical-adjacent: check the action before it executes, escalate anything sensitive to a human. That is precisely the "route, acknowledge and schedule — never answer clinically" line this digest keeps drawing, except implemented as software instead of as a policy nobody reads. Three — treat an agent like a new hire on the network. Pennarun's framing is the one to repeat to a practice owner: you would not hand a new employee unlogged access to the whole chart system on day one, and an agent does not earn an exception for being fast. :barchart: Source note: TechCrunch is on the time-boxed promotion default announced Sep 17 — it moves to Trusted on Mon, Sep 22 on its record (5+ supplied items, two :+1:, zero :-1:) unless someone objects. A :-1: here or a reply is an objection; silence will be read as consent. Restating once, not daily. TechCrunch — "The fix for rogue AI agents could be more AI"

Stripe's head of data and AI says the fraud moved: attackers now want your tokens, not your money — and most businesses have already decided whether an agent can buy from them without realizing it

Nate B Jones · "Most Attacks On AI Companies Happen Before Checkout. Fraudsters Want Tokens." · September 17, 2026Buildable AI

Why it matters for an independent practice: One — this is the other half of item 1, which is why it runs today. Item 1 is a seller charging an agent for access; this is the buyer's side and the fraud surface sitting between them. Any practice that ever lets an agent transact — booking a paid consult, ordering supplies, moving ad budget — inherits both sides at once. Two — "a spending limit cannot authorize everything" is the sentence to carry into every practice automation. A cap controls the amount; it does not constitute consent. Approving a $200 ceiling for an agent is not approving what it chooses to buy, and for anything patient-facing the approval has to be per action, not per budget. Three — the fraud-rules point has an immediate MMR read. Rules tuned to catch bad humans will silently decline a legitimate agent, and within a year that means turning away a real patient whose assistant tried to book on their behalf. Worth knowing today which of a client's booking and payment paths would currently reject a bot, because that is a revenue question disguised as a security setting. :warning: Shape note: this is an interview, not a build — and a hands-on build is the single most-stated preference on file. Nate Herk's build video ran yesterday, and nothing fresher on a builder channel was date-verifiable this morning (Sabrina Ramonov's newest is a two-day-old tool-switching video, not a build; two other builder channels rendered no video list at all). This is the strongest fresh, date-verified, on-lens video available, and it is a Trusted source. :-1: if the interview shape doesn't earn the slot and I'll hold it next time rather than substitute. YouTube — Nate B Jones, "Most Attacks On AI Companies Happen Before Checkout. Fraudsters Want Tokens." (30:49)

Sheba Medical Center cut chemo delivery from ~40 minutes to 14 — and the lesson wasn't the robot, it was that nothing in the building knew what anything else was doing

Healthcare IT News · Sep 18, 2026 · September 18, 2026Practice operations

Why it matters for an independent practice: Strip out the robots and this is a small-clinic problem at a smaller scale: the scheduler, the intake form, the imaging order, the injectable prep and the room turnover all work fine individually and none of them knows what the others are doing, so the bottleneck is always somebody walking down a hall to ask. The transferable move for a regen practice is the cheap version of the same layer — one system that sees the whole day's tasks and reassigns them by urgency, rather than five tools each optimizing their own slice. The metric discipline is worth stealing outright: stop counting automations shipped, start counting minutes of clinical time returned.

An AI longevity company published its own grading rubric in Cell — the benchmark, the models and the agent platform, all open — eleven days after its AI-discovered drug moved biological age in a Phase IIa

Longevity.Technology · Sep 18, 2026 · September 18, 2026Regenerative medicine

Why it matters for an independent practice: The interesting move is the benchmark, not the drug. Publishing the rubric you want to be graded against is the opposite of how most AI-in-longevity claims arrive at a clinic — usually as a vendor deck with a proprietary score nobody outside can reproduce. That gives an independent regen practice a concrete question to put to every longevity or "biological age" product that walks in the door: against what public benchmark, evaluated by whom, and can I read the paper? It also sets up the harder conversation on the other side of the desk — patients are going to read "AI-discovered drug lowered biological age across six clocks" and ask what the practice can offer that's equivalent, and the honest answer for most of what's currently sold under that banner is nothing at this evidence level yet.

The bug had already been fixed months earlier — but nobody gave it a CVE number, so the patch was invisible and the server stayed open. Three people and a $200/month subscription got into OpenAI employee accounts.

TechCrunch · Sep 18, 2026 · September 18, 2026Buildable AI

Why it matters for an independent practice: Zero medical content, and the extrapolation is a question to put in writing to every vendor holding patient data. The CVE blind spot is the finding. Every practice-side security answer — the EHR vendor's, the intake form's, the patient-portal's, the scheduling widget's — rests on "we patch known vulnerabilities," and known means has a CVE. This is a worked example of a real, fixed, publicly-available patch that no tracker ever listed, sitting exploitable inside a stack that was doing everything by the book. Two concrete asks for a BAA-covered vendor: do you track your transitive dependencies' upstream commits, or only CVE feeds? and what's your update lag on a library you didn't know was vulnerable? The cost side is the second half — if a three-person team with a consumer subscription can do this to OpenAI, "we're too small to be a target" stopped being an argument, because the expertise that used to price small clinics out of the attacker's attention just got cheap.

He passed $10K/month as a solo AI freelancer, then ran Dario Amodei's three filters for a one-person company against his own idea list on camera — including a "mystery shopper" step and the actual $1M math

Nate Herk | AI Automation · uploaded Sep 18, 2026 · September 18, 2026Buildable AI

Why it matters for an independent practice: This is the standing "0% medical, extrapolate" shape: nothing here mentions a clinic, and the whole thing maps onto both sides of Atiba's world. For MMR, it's a pricing-and-capacity model for productized services delivered by one operator plus agents — the relevant question being which deliverables survive without a human in the loop and which never will. For an independent practice, the same filters are the honest test of "should we build this ourselves or buy it": if the $1M math doesn't close at zero headcount, the automation is a cost centre, not leverage. The mystery-shopper step is the cheapest thing on this list and the one nobody does — call three competing regen clinics as a patient before rewriting a single service page. • :warning: Disclosure: the description carries affiliate links (Clay, Hostinger, Glaido) and promotes the creator's own paid community. Watch it for the filters and the math, not the tool picks. Anthropic's CEO: How to Build a 1 Person Business with Claude — Nate Herk | AI Automation, Sep 18, 11:40 Date verified from the watch page's `uploadDate` meta: `2026-09-18T06:01:25-07:00`.